Dr. Hope S. Rugo on the SOPHIA Trial in HER2+ Breast Cancer

Leggi l'articolo originale


Cancer Network spoke with Hope S. Rugo, MD, of the University of California, San Francisco, about the results of the phase III SOPHIA trial in HER2-positive breast cancer.

Lascia un commento